蛋白与蛋白的相互作用和相关的抑制剂参与了NLRP3炎症酶通路
Zhen-Yu Ma1, Cheng Jiang1, Li-Li Xu1
1Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China; Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, China Pharmaceutical University, Nanjing 210009, China.
Cytokine & growth factor reviews
|September 27, 2023
概括
在慢性疾病中,NLRP3炎症酶至关重要. 本综述强调了NLRP3激活中的蛋白-蛋白相互作用,并探讨了针对这些相互作用的小分子抑制剂,以获得治疗益处.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 类似NOD的受体热蛋白域相关蛋白3 (NLRP3) 炎症体是天生的免疫的关键组成部分.
- NLRP3的激活与许多慢性炎症疾病的发病有关.
- 了解NLRP3炎症酶组合和激活对于开发向疗法至关重要.
研究的目的:
- 审查NLRP3炎症酶激活途径中的蛋白质-蛋白质相互作用 (PPI).
- 要总结针对这些PPI的小分子抑制剂.
- 突出针对慢性疾病的NLRP3 PPI的治疗潜力.
主要方法:
- 关于NLRP3炎症酶激活通路的研究文献综述.
- 对NLRP3寡合体构成的冷电子显微镜 (cryo-EM) 数据的分析.
- 对旨在破坏NLRP3相关PPI的小分子抑制剂的调查.
主要成果:
- 化EM已经阐明了NLRP3的寡合体构造,进步了机械学的理解.
- 蛋白质与蛋白质的相互作用是NLRP3炎症酶组合和激活的基础.
- 针对PPI的小分子抑制剂为NLRP3过度激活提供了有前途的治疗策略.
结论:
- 针对NLRP3炎症体内的蛋白质-蛋白质相互作用,代表了一种新的治疗途径.
- 小分子抑制剂在调节NLRP3.3方面显示出有效性和良好的安全性.
- 对NLRP3 PPI的进一步研究可以加速慢性炎症病的治疗方法的开发.
相关概念视频
Protein-protein Interfaces
12.5K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K
NF-κB-dependent Signaling Pathway
7.5K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.5K
Regulation of the Unfolded Protein Response
2.5K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.5K
The Intrinsic Apoptotic Pathway
6.6K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K
The Unfolded Protein Response
4.7K
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
4.7K
The JAK-STAT Signaling Pathway
9.0K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.0K


